| Dr Mark Robert Adams Jr, DPT | |
|
2720 8th St Sw Ste B, Altoona, IA 50009-1028 | |
| (515) 957-8609 | |
| (515) 957-9264 |
| Full Name | Dr Mark Robert Adams Jr |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 2720 8th St Sw Ste B, Altoona, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053804229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 090391 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Younker Rehabilitation Therapy Services Llc | 2062799810 | 38 |
News Archive
Negotiations to reconcile House and Senate versions of legislation that would promote the implementation of health care information technology have not progressed, and prospects for passage of a final bill prior to the midterm elections are uncertain, according to congressional aides, CongressDaily reports (Lee, CongressDaily, 9/12).
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
A new study has shown that the compound resveratrol found in red wine demonstrates stress relieving effects in anxiety and depression. This could be due to resveratrol's ability to control an enzyme in the brain that is liked to stress say the researchers from the University at Buffalo in collaboration with Xuzhou Medical University in China.
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
› Verified 5 days ago
| Provider Name | Younker Rehabilitation Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1447797113 PECOS PAC ID: 2062799810 Enrollment ID: O20170503001109 |
News Archive
Negotiations to reconcile House and Senate versions of legislation that would promote the implementation of health care information technology have not progressed, and prospects for passage of a final bill prior to the midterm elections are uncertain, according to congressional aides, CongressDaily reports (Lee, CongressDaily, 9/12).
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
A new study has shown that the compound resveratrol found in red wine demonstrates stress relieving effects in anxiety and depression. This could be due to resveratrol's ability to control an enzyme in the brain that is liked to stress say the researchers from the University at Buffalo in collaboration with Xuzhou Medical University in China.
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Robert Adams Jr, DPT 1200 Pleasant Street, South 2 Room 236, Des Moines, IA 50309 Ph: (515) 241-6228 | Dr Mark Robert Adams Jr, DPT 2720 8th St Sw Ste B, Altoona, IA 50009-1028 Ph: (515) 957-8609 |
News Archive
Negotiations to reconcile House and Senate versions of legislation that would promote the implementation of health care information technology have not progressed, and prospects for passage of a final bill prior to the midterm elections are uncertain, according to congressional aides, CongressDaily reports (Lee, CongressDaily, 9/12).
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
A new study has shown that the compound resveratrol found in red wine demonstrates stress relieving effects in anxiety and depression. This could be due to resveratrol's ability to control an enzyme in the brain that is liked to stress say the researchers from the University at Buffalo in collaboration with Xuzhou Medical University in China.
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
› Verified 5 days ago
Athletico Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 8th St Sw, Ste M & N, Altoona, IA 50009 Phone: 515-967-4580 Fax: 515-967-4899 | |
Cole Jarrard, Physical Therapist Medicare: Medicare Enrolled Practice Location: 612 8th St Sw, Altoona, IA 50009 Phone: 515-967-4124 | |
Brenda Catherine Stein, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 8th St Sw, Suite 1, Altoona, IA 50009 Phone: 515-967-4580 Fax: 515-967-4899 | |
Celeste Rodriguez Bartelt, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3770 8th St Sw, Suite A, Altoona, IA 50009 Phone: 515-967-5025 Fax: 515-967-2360 | |
Elizabeth Ann Rivenburgh, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2720 8th St Sw Ste B, Altoona, IA 50009 Phone: 515-957-8609 Fax: 515-957-9264 | |
Ryan J Domeyer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 8th St Sw, Suite 1, Altoona, IA 50009 Phone: 515-967-4580 Fax: 515-967-4899 |